SynthesisJournal of epidemiology and global health2025
Epidemiology of Chronic Suppurative Otitis Media: Systematic Review To Estimate Global Prevalence.
Synthesis in Journal of epidemiology and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Utilization of human amniotic membrane (HAM) in tympanoplasty: a systematic review and meta-analysis.Cell and tissue banking · 2026Pooled it
- Article
- Article
- Complication pattern of chronic suppurative otitis media in North Indian subjects.Bioinformation · 2026Article
- Effects of levofloxacin combined with dexamethasone ear drops on suppurative otitis media and analysis of influencing factors.American journal of translational research · 2026Article
- Biofilm Formation and Its Relationship with the Microbiome in Pediatric Otitis Media.Microorganisms · 2025Review
- Article
- Role of imaging in chronic otitis media and its complications.World journal of radiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic Suppurative Otitis Media (CSOM) is a disorder characterised by a perforation of the tympanic membrane leading to ear discharge and hearing loss, a disability causing marginalisation in employment, education, social stigma, and reduced wellbeing and quality of life. Previous studies on the global epidemiology of this condition, despite methodological limitations, have estimated global prevalence at 200 million.
methodsAdhering to PRISMA guidelines, published literature was systematically reviewed across Ovid and Embase databases, with original community-based studies on CSOM published from 2004 to March 19th, 2025 extracted for final consideration on quality and relevance. Studies focusing on hospital populations were excluded as they seem more likely to represent a biased group of severe cases. Published articles were analysed for data on CSOM prevalence and associated risk factors.
resultsFrom 5,394 articles, 29 cross-sectional studies met the inclusion criteria. Included studies predominantly originated from low- and middle-income countries (LMICs) and focused on paediatric populations. A pooled average estimate revealed a CSOM global prevalence of 3.8% of the global population, or 297 million people, 85% (252 million) of which in LMICs. 64 million (21.5%) of those affected had bilateral disease, and 184 million (62%) had disabling hearing loss defined as > 25-30 dB. Hearing impairment was reported in only four studies, which affected 50-78% of participants. Frequency of ear discharge was reported in only one study.
conclusionThe study identifies a significant global burden of CSOM, disproportionately affecting LMICs, and signals to healthcare providers and policymakers a pressing need for initiatives to prevent and manage this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.